Page 34 - JCTR-10-2

128 Abtahi et al. | Journal of Clinical and Translational Research 2024; 10(2): 119-140
Nair RV, Shaikh K, et al. Clinical Decision Support for [61] Tanaka T, Narazaki M, Kishimoto T. IL-6 in Inflammation,
Primary Health Centers to Combat COVID-19 Pandemic. In: Immunity, and Disease. Cold Spring Harb Perspect Biol
Intelligent Systems. Germany: Springer; 2021. p. 481-90. 2014;6:a016295.
[48] Mellitus D. Diagnosis and Classification of Diabetes doi: 10.1101/cshperspect.a016295
Mellitus. Diabetes Care 2005;28:S5-10. [62] Lala V, Goyal A, Bansal P, Minter DA. Liver Function
doi: 10.2337/diacare.28.suppl_1.s37 Tests. In: StatPearls. Treasure Island, FL: StatPearls; 2021.
[49] Garg AD, Agostinis P. Cell Death and Immunity in Cancer: [63] Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, et al. COVID-19:
From Danger Signals to Mimicry of Pathogen Defense Abnormal Liver Function Tests. J Hepatol 2020;73:566-74.
Responses. Immunol Rev 2017;280:126-48. doi: 10.1016/j.jhep.2020.04.006
doi: 10.1111/imr.12574 [64] Takeda Y, Takeda Y, Tomimoto S, Tani T, Narita H,
[50] Miller KD, Nogueira L, Mariotto AB, Rowland JH, Kimura G. Bilirubin as a Prognostic Marker in Patients
Yabroff KR, Alfano CM, et al. Cancer Treatment with Pulmonary Arterial Hypertension. BMC Pulmonary
and Survivorship Statistics, 2019. CA Cancer J Clin Med 2010;10:22.
2019;69:363-85. doi: 10.1186/1471-2466-10-22
doi: 10.3322/caac.21565 [65] Lala V, Goyal A, Farhana A, Lappin SL. Biochemistry,
[51] Timmis A, Townsend N, Gale CP, Torbica A, Lettino M, Lactate Dehydrogenase. In: StatPearls. Treasure Island,
Petersen SE, et al. European Society of Cardiology: FL: StatPearls Publishing; 2021.
Cardiovascular Disease Statistics 2019. Eur Heart J [66] Du Clos TW, Mold C. C-Reactive Protein: An Activator of
2019;41:12-85. Innate Immunity and a Modulator of Adaptive Immunity.
doi: 10.1093/eurheartj/ehz859 Immunol Res 2004;30:261-77.
[52] Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. doi: 10.1385/IR:30:3:261
Prevalence of Chronic Kidney Disease in China: A Cross- [67] Creamer AW, Kent AE, Albur M. Procalcitonin in Respiratory
Sectional Survey. Lancet 2012;379:815-22. Disease: Use as a Biomarker for Diagnosis and Guiding
doi: 10.1016/S0140-6736(12)60033-6 Antibiotic Therapy. Breathe (Sheff) 2019;15:296-304.
[53] Hansell DM. Classification of Diffuse Lung Diseases: Why doi: 10.1183/20734735.0258-2019
and How. Radiology 2013;268:628-40. [68] Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM.
doi: 10.1148/radiol.13120908 Ferritin for the Clinician. Blood Rev 2009;23:95-104.
[54] Rosselli M, MacNaughtan J, Jalan R, Pinzani M. Beyond doi: 10.1016/j.blre.2008.08.001
Scoring: A Modern Interpretation of Disease Progression [69] Sharma S, Jackson PG, Makan J. Cardiac Troponins. J Clin
in Chronic Liver Disease. Gut 2013;62:1234-41. Pathol 2004;57:1025-6.
doi: 10.1136/gutjnl-2012-302826 doi: 10.1136/jcp.2003.015420
[55] Rose NR. Autoimmune Diseases. In: Quah SR, editor. [70] Tripodi A. D-Dimer Testing in Laboratory Practice. Clin
International Encyclopedia of Public Health. 2 ed. Chem 2011;57:1256-62.
nd
Oxford: Academic Press; 2017. p. 192-5.
[56] Krensky M, Bennett M, Vincenti F. In: Brunton LL, editor. doi: 10.1373/clinchem.2011.166249
Immunosuppressants, Tolerogens, and Immunostimulants. [71] Hepner M, Karlaftis V. Antithrombin. Methods Mol Biol
McGraw-Hill Education; 2011. p. 1005-31. 2013;992:355-64.
[57] Schiffrin EL, Flack JM, Ito S, Muntner P, Webb RC. doi: 10.1007/978-1-62703-339-8_28
Hypertension and COVID-19. United States. Country in [72] Herrick S, Blanc-Brude O, Gray A, Laurent G. Fibrinogen.
North America. Oxford University Press; 2020. Int J Biochem Cell Biol 1999;31:741-6.
[58] Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. doi: 10.1016/s1357-2725(99)00032-1
Defining Comorbidity: Implications for Understanding [73] Inker LA, Levey AS, Coresh J. Estimated Glomerular
Health and Health Services. Ann Fam Med 2009;7:357-63. Filtration Rate from a Panel of Filtration Markers-Hope
doi: 10.1370/afm.983 for Increased Accuracy Beyond Measured Glomerular
[59] George-Gay B, Parker K. Understanding the Complete Filtration Rate? Adv Chronic Kidney Dis 2018;25:67-75.
Blood Count with Differential. J Perianesth Nurs doi: 10.1053/j.ackd.2017.10.004
2003;18:96-114, quiz 115-7. [74] Magee F, Wilson A, Bailey M, Pilcher D, Gabbe B,
doi: 10.1053/jpan.2003.50013 Bellomo R. Comparison of Intensive Care and Trauma-
[60] Walker HK, Hall WD, Hurst JW. Clinical Methods: The specific Scoring Systems in Critically Ill Patients. Injury
History, Physical, and Laboratory Examinations. Boston: 2021;52:2543-50.
Butterworths; 1990. doi: 10.1016/j.injury.2021.03.049
DOI: https://doi.org/10.36922/jctr.22.00226